A Phase 3 Study of [177Lu]Ludotadipep for Metastatic Castration-Resistant Prostate Cancer
A Phase 3 Study of [177Lu]Ludotadipep for Metastatic Castration-Resistant Prostate Cancer
Recruiting · NCT07853209 · Registry updated 2026-10-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Study of [177Lu]Ludotadipep for Metastatic Castration-Resistant Prostate Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 3 | 2026-10-01 | NCT07853209 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| FutureChem | 3 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ewha Woman University Medical Center | Seoul | South Korea | 1 |
| Korea University ANAM Hospital | Seoul | South Korea | 56 |
| National Cancer Center | Gyeonggi-do | South Korea | 6 |
| Samsung Medical Center | Seoul | South Korea | 170 |
| Seoul National University Hospital | Seoul | South Korea | 183 |
| Seoul St. Mary's Hospital | Seoul | South Korea | 13 |
| Severance Hospital | Seoul | South Korea | 62 |
| St. Vincent's Hospital | Suwon | South Korea | 1 |